The Companies Powering the Buildout and Why the Smartest Money on Wall Street Is Crowding In A nine-company infrastructure portfolio including AmpliTech Group (NASDAQ: AMPG) as a featured essential play and positioned for the largest capital-deployment cycle in modern history. Executive Summary The artificial-intelligence buildout has become
★ MAJOR BUY RECOMMENDATION ★ AmpliTech Group (NASDAQ: AMPG) The Forgotten Winner of the Satellite-to-Phone Trade PART I — Recommendation: MAJOR BUY (AMPG) This is a major buy recommendation on a totally overlooked stock. Wall Street is staring at the wrong end of the satellite-to-cell revolution — fixated on Starlink&
How ReBalU's endogenous butyrate and DHA systematically influence 18 validated longevity genes, and how the test/treat/retest platform compensates for the genetic insufficiencies that determine how fast you age. This is Part Two of a two-part series on the ReBalU protocol and longevity biology. Part One
Horizon: 24 Months (through May 2028) | Rating: Strategic Buy / Acquisition Candidate Current Price: $5.23 | 24-Month Blended Target: $28.40 | Upside: +443% Strategic Takeout Range: $13.00 – $32.00 | Standalone Discounted Range: $41 – $70 1. Executive Summary AmpliTech Group is the only US supplier of a commercial-grade 64T64R
New research from the Buck Institute finally explains why some people age dramatically slower. A precision nutrition protocol called ReBalU is engineered to give everyone else the same advantage. This is Part One of a two-part series on the ReBalU protocol and longevity biology. Part Two goes deep on
Investment Highlights * Trading at Just $1.00 per Share — Extraordinary asymmetric entry point relative to FY2027/FY2028 forecast trajectory * Pure-Play Agentic AI Business Model — AI ERA operates UFilm.ai and licenses its proprietary agentic AI script-making technology to UFlix.ai (and intends to license to additional platforms), while
Executive Summary Human papillomavirus is one of the most common sexually transmitted infections. Almost all sexually active people encounter it at some point, usually without symptoms and usually with natural immune clearance. Yet the clinical burden is enormous. Persistent infection with carcinogenic HPV types leads to cervical precancer and cancer
This is Part Three of a three-part series on agentic AI and the U.S. economy. Part One laid out the macro thesis and scenario framework — why mainstream forecasts are structurally wrong and what the services-first math actually produces. Part Two examined the 1923–29 Roaring Twenties analog
This is Part Two of a three-part series on agentic AI and the U.S. economy. Part One laid out the macro thesis and the scenario framework — the services-first case for why mainstream forecasts are structurally wrong and what the correct math actually produces. Part Three will translate
This is the first installment in a three-part series on agentic AI and the U.S. economy. Part One lays out the macro thesis and the data behind it. Part Two examines the closest historical analog, the Roaring Twenties productivity boom of 1923 to 1929, and what it tells
In late 2018, a 68-year-old man walked into a birthday party in Epuyen, Argentina. He had just started running a fever. He stayed for 90 minutes. Around 100 people were at that party. What happened next killed 11 people and infected 34. The culprit was the Andes hantavirus
For more than two decades, one rule quietly separated smaller retail traders from the kind of active trading access available to larger accounts. That barrier is now coming down. The SEC's approval of FINRA's new intraday margin framework will eliminate the old Pattern Day Trader rule,